In this study, we developed a mouthpiece-type gel
dosimeter to prevent the
oral mucositis caused by the perturbation effect of
dental alloys in the
radiotherapy of the head and neck regions and to enable in vivo dosimetry. Understanding the dose distribution in the oral cavity during
radiotherapy helps identify the possible site for
oral mucositis during treatment. Here
agarose, which has a higher melting point than
gelatin, was added as a
coagulant to stabilize the shape of the
dosimeter. The strength and dose response of the
dosimeter were investigated. The strength was measured at room temperature, 20°C-40 °C, which is higher than the intraoral temperature. The dose-response curves were obtained by magnetic resonance imaging with R2 ranging from 0 to 25 Gy. The strength and dose response of the mouthpiece-type gel
dosimeter were approximately 4 and 2.1 times higher than those of
polyacrylamide gel and
tetrakis hydroxymethyl phosphonium chloride dosimeters commonly used in the prescribed doses per fraction of treatment. The
dosimeter is composed of 4 wt%
MgCl2 and 1.5 wt%
agarose; thus, it can retain the water equivalence. Through in vivo oral dosimetry in three dimensions for head and neck
radiotherapy with
dental alloys using the mouthpiece-type gel
dosimeter, we obtained three-dimensional dose distributions in the
dosimeter. The properties of the
dosimeter show that it can be used in the clinic, depending on the prescribed dose.